Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21: A Randomized Clinical Trial. - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Accéder directement au contenu
Article Dans Une Revue JAMA Cardiology Année : 2018

Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21: A Randomized Clinical Trial.

. Safe 21 Study Group
  • Fonction : Auteur

Résumé

ClinicalTrials.gov Identifier: NCT02127515.

Dates et versions

hal-02624442 , version 1 (26-05-2020)

Identifiants

Citer

Valérie Malan, Laurence Bussières, Norbert Winer, Jean-Philippe Jais, Amandine Baptiste, et al.. Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21: A Randomized Clinical Trial.. JAMA Cardiology, 2018, 320 (6), pp.557-565. ⟨10.1001/jama.2018.9396⟩. ⟨hal-02624442⟩
19 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More